Increase in size of the pulmonary autograft after the ross operation in children: Growth or dilation?  by Solymar, Laszlo et al.
4ever, have the potential of maintained function and
growth. Although previous studies in animals5,6 and
human subjects7 have shown that the resected pul-
monary valves can maintain viability, there is still lim-
ited knowledge about the long-term effects of the resec-
tion of the pulmonary root and its transfer into the aortic
position, especially when performed in small children.
The few reports published on the change in the size of
the pulmonary autograft in children8-11 do not allow a
distinction between passive dilation and active growth.
We have performed the Ross procedure in selected
infants since 1991, and because young infants are in the
phase of very rapid somatic growth, they seem espe-
cially suitable for study to distinguish between growth
and dilatation. We have also followed a group of healthy
infants to assess the normal growth rate of the relevant
aortic segments.
Patients and methods
Eight survivors of infantile aortic valve replacement with
pulmonary autograft were enrolled into the study. Clinical and
A lthough the majority of infants with severe aorticstenosis can receive palliation by commissurotomy
or dilation procedures, a few require aortic valve re-
placement. In this the options are to use homografts or
to perform an autotransplantation of the pulmonary
valve into the aortic position (ie, the Ross operation).1
There is increasing evidence that homografts lack the
potential of growth and become dysfunctional because
of calcific degeneration.2-4 Pulmonary autografts, how-
Objective: We sought to assess growth properties of the pulmonary auto-
graft after the Ross operation in children. Methods: Eight infants with
critical aortic stenosis who underwent the Ross operation early in life
(median age, 6.4 months) were followed up regarding the possible
growth of the autograft. The pulmonary autograft was measured
repeatedly by echocardiography during the follow-up, ranging from 6
months to 7 years (median, 5.2 years). Twelve normal children who
served as control subjects were similarly followed from 3.9 to 5.8 years
(median, 4.9 years). Results: Somatic growth during the follow-up period
was significant and was reflected in a doubling of the body surface area,
which increased from 0.33 ± 0.14 m2 to 0.74 ± 0.21 m2. The proximal
part of the autograft increased from 13.6 ± 3.6 mm to 23.3 ± 3.7 mm
(mean ± SD) and the distal part from 10.5 ± 2.5 mm to 15.9 ± 2.8 mm.
Growth pattern of the autograft was analyzed by relating measured
diameters to predicted normal diameters (ie, Z values). During the first
year after the operation, the mean Z value of the proximal autograft
increased from 0.2 to 2.2, indicating a more rapid increase than the pre-
dicted increase and was also significantly higher than that of the control
group (P = .01). After the first year, Z-value changes in patients and con-
trol subjects were very similar. Conclusions: We thus conclude that the
pulmonary autograft in the aortic position after the Ross operation does
increase in size and that the pattern of this increase is suggestive of pas-
sive dilation in the early postoperative period, followed by normal active
growth. (J Thorac Cardiovasc Surg 2000;119:4-9)
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surgical data of 6 of these patients have been reported else-
where.12 Of the 2 additional patients, 1 had a primary aortic
valve replacement with a homograft that became severely
stenotic and regurgitant, and the other was a prematurely
born baby (birth weight, 1.5 kg) who was treated with com-
missurotomy at the age of 1 month but continued to have
significant stenosis and required repeated intervention. All
patients were monitored with repeated echocardiographic
studies, including 2-dimensional, Doppler, and color flow
mapping. Echocardiograms were assessed for all subjects
within 14 days of the operation and at 6 months, 12 months,
and then yearly thereafter. Two to three measurements at
the level of the sinus of Valsalva and at the distal anasto-
mosis (sinoaortic junction) were obtained in systole and were
Fig 2. Time-related changes in the mean Z-values ± SEM of the proximal autograft and the aortic root in patients
and respective control subjects.
Fig 1. Individual measurement data on the proximal autograft diameters at surgery and during follow-up. The
shaded area represents the 95% confidence intervals of the control group.
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averaged. Preoperative pulmonary arterial pressure was
assessed by cardiac catheterization in 2 patients and by
echocardiography through the TR gradient in 5 patients.
Demographic, anatomic, and clinical data at the time of
surgery are given in Table I. The follow-up ranged from 0.5
to 7 years (median, 5.2 years). Because somatic growth could
not be expected to be linear during follow-up, measurements
were transformed to Z-values to normalize somatic growth,
as suggested by Rimoldi and Lev.13 In the calculation of Z-
values, the data of Roman and colleagues14 were used as ref-
erence data. For comparison, 12 infants with diagnoses of
insignificant muscular ventricular septal defects or physio-
logic murmurs were included as control subjects after institu-
tional review board approval. Written consent was obtained
for each patient. These control subjects were followed up
from early infancy to school age (median, 4.9 years; range,
3.9 to 5.8 years), and repeated measurements of the aortic
segments corresponding to those in the patient group were
obtained at similar time intervals. As in our patients, Z-values
were calculated by using the data of Roman and colleagues.14
Comparisons between patients and control subjects were
made by using the unpaired t test, and comparisons within
each group, but at different ages, were made by using the
paired t test.
Results
There was 1 late death; patient 4 died at the age of 1
year of hypertrophic obstructive cardiomyopathy and
severe pulmonary hypertension. All the others are
Table I. Associated anomalies, previous palliations, and demographic and clinical data at the time of the 
Ross operation
Patient 
No. Sex Associated anomalies Previous palliation
1 F Severe mitral regurgitation, 1. Transventricular dilation 
endocardial fibroelastosis 2. Transventricular dilation
2 M Coarctation of the aorta, 1. Coarctation repair and transventricular dilation 
endocardial fibroelastosis 2. Commissurotomy
PDA, ASD
3 M Mitral regurgitation Transventricular dilation
4 M Hypertrophic obstructive 1. Commissurotomy 
cardiomyopathy, PHT 2. Balloon dilation
5 M None Transventricular dilation
6 M None 1. Transventricular dilation 
2. Aortic homograft
7 M None 1. Subaortic resection 
2. Balloon dilation
8 M None Transventricular dilation
AVR, Aortic valve replacement; AS, aortic stenosis; PDA, persistent ductus arteriosus; ASD, atrial septal defect; PHT, pulmonary hypertension.
Table II. Anatomic and hemodynamic data of the patients immediately after the Ross operation and at the last
follow-up 
Immediately after surgery At the latest follow-up 
Proximal Distal Proximal Distal 
Age BSA autograft autograft Aortic Age BSA autograft autograft Aortic 
Patient (mo) (m2) (mm) (mm) regurgitation* (mo) (m2) (mm) (mm) regurgitation
1 1.5 0.21 12.2 10.3 +1 85.5 0.79 25.4 15.6 +1
2 2.5 0.22 14.5 8.5 0 79 0.75 28.6 16.5 0
3 5.6 0.29 11.1 10.1 +1 81.6 1.06 25.2 15.8 +1
4 3.9 0.29 11.7 9.0 0 11 0.35 17.4 10.3 0
5 18 0.48 18.7 14.6 0-+1 79 0.78 24.6 19.5 +1
6 1.4 0.25 12.0 8.6 0 64.4 0.75 22 16.5 0
7 39 0.61 19.3 12.7 0 99 0.96 25.3 18.6 0
8 3.0 0.25 10.1 7.4 0 38.5 0.59 20 14 +1
Mean 9.4 0.33 13.7 10.2 67.3 0.75 23.6 15.9
SD 12.3 0.14 3.28 2.25 28 0.21 3.56 2.82
*Regurgitation validated by color Doppler area: 0, none; 0-+1, trivial; +1, mild; +2, moderate; +3, severe.
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symptom free and doing well, and the patient having
previous repair of coarctation did not have any evi-
dence of arch obstruction.
The substantial somatic growth of the patients dur-
ing the follow-up period was reflected in a tripling of
body weight, which increased from 6.3 ± 3.8 kg to
18.7 ± 7.3 kg (mean ± SD) and in a doubling of the
body surface area, increasing from 0.32 ± 0.14 m2 to
0.75 ± 0.21 m2. During this period, the mean diameter
of the proximal autograft increased from 13.7 ± 3.5
mm to 22.6 ± 3.5 mm (P = .0001), and the distal anas-
tomosis increased from 10.2 ± 2.4 mm to 15.9 ± 2.8
mm (P = .001). Individual patient data are given in
Table II, and individual measurements of autograft
diameters with increasing age are shown in Fig 1. In
most patients the proximal autograft diameter increas-
es rapidly within the first year to reach and also
exceed the upper range of the aortic root diameter of
the control subjects. As previously pointed out, the
use of Z-values allows assessment of growth pattern
because increase related to somatic growth is includ-
ed in each prediction. Fig 2 shows the development of
the proximal autograft of the patients and the aortic
root of the control subjects as group means of the Z-
values and bars of SEM. During the first postoperative
year, the Z-value of the proximal autograft increased
from 0.2 ± 0.50 to 2.2 ± 0.38, which significantly
exceeded the first-year increase of the control subjects
from –0.9 ± 0.12 to 0.1 ± 0.20 (P = .01, Table III).
During subsequent follow-up, both patients and con-
trol subjects had a slow progressive increase of the
mean Z-values, but the difference between patients
and control subjects was not statistically significant
(Fig 2 and Table III).
The changes in the distal part of the autograft and
corresponding measurements of the ascending aorta of
the control subjects are shown in Fig 3. A progressive
increase in the mean Z-values in both patients and con-
trol subjects can be seen, and there was no significant
difference between the 2 groups at any time during fol-
low-up (Table III).
Discussion
The Ross operation may be especially suited for
small infants needing aortic valve replacements
because mechanical valves are too bulky to be accom-
Table III. Changes in the mean Z-score values during the first year and during further follow-up and comparison
between patients and control subjects
Time Proximal Distal Ascending 
period (mo) n autograft n Aortic root P value n autograft n aorta P value
0-12 8 2.00 (0.53)* 10 1.11 (0.47) .009 8 0.76 (0.74) 9 0.74 (0.46) .9
12-60 6 1.13 (0.80) 10 0.82 (0.40) .4 6 1.26 (0.52) 10 1.01 (0.55) .6
*Values in brackets indicate SD.
Age at Age at Weight at Pulmonary 
previous palliation (d) Indication for AVR AVR (mo) AVR (kg) hypertension
1. 1, 2. 15 Congestive heart failure 1.5 3.2 Yes
1. 6, 2. 8 Congestive heart failure, residual AS 1.7 3.5 Yes
2 Avulsion of the aortic valve, residual AS 5.5 5.2 No
1. 3, 2. 66 Congestive heart failure, residual AS, angina 4 5.4 Yes
2 Avulsion of the aortic valve, aortic regurgitation 1.5 10.9 No
1. 3, 2. 35 Homograft stenosis and regurgitation 17 4.6 Yes
1. 60, 2. 270 Subvalvular aortic stenosis 3 13.6 Yes
10 Residual aortic stenosis 3 4.2 No
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modated in the heart of the infant, and homografts in
the systemic position have been found to malfunction
early2-4 and seem to lack growth potential.15 The pul-
monary autograft, being the patient’s own tissue, is not
subject to immunologic degenerative changes, but the
surgical procedure involves transection of the vessels
supplying the arterial wall, which may affect vessel
wall mechanics and growth. In animal experiments
such a transection was not found to prevent normal
growth in isolated vessel segments6,16,17 or in valved
segments.5,6 Explanted pulmonary autografts have also
been found to have a viable vessel wall in human sub-
jects7 and thus a potential for growth in growing
patients. Our study design aimed at assessing the
growth pattern in a rapidly growing group of patients
(ie, those undergoing the Ross procedure during early
infancy). We could distinguish two patterns of diameter
increase: one rapid one within the first year after
surgery (most of which occurred in the first 6 months)
and a slower one in the years thereafter. Several previ-
ous reports, with a fairly short follow-up, have shown a
similar rapid increase in size soon after opera-
tion.8,10,11,18,19 Such a rapid increase in dimension is
suggestive of passive dilation, and this mechanism is
not surprising because the wall thickness and the num-
ber of elastic layers in the pulmonary artery are signif-
icantly smaller and less well organized than those of
the aorta.20 In a recent animal study, Schoof and col-
leagues6 demonstrated a passive dilation of the pul-
monary autograft, both valved and nonvalved, attribut-
able to differences in vessel wall anatomy. In spite of
this, in clinical experience progressive dilation leading
to significant regurgitation has been seen only in a
minority of cases with the pulmonary valve in the sys-
temic position.7,21,22 Also in our study, aortic regurgita-
tion was trivial or very mild directly after operation,
and there was no evidence of significant progression
during follow-up, despite the noted dilation. The main-
tained function may be attributed to the growth and
remodeling of valve cusps, as found in the animal
model,6 withstanding a moderate dilation of the aortic
sinus. Elkins and colleagues22 followed a large number
of older children and showed that intra-aortic replace-
ments tended to follow a normal diameter increase,
whereas root replacements tended to dilate. All of our
patients had aortic root replacement because they were
small infants. Nevertheless, there was no clear evi-
dence of progressive dilation after the first postopera-
tive year, after which the growth pattern of the auto-
graft was very similar to that seen in the control group
and probably represents normal active growth. Al-
though the Z-values continued to increase, even after
the first year, this pattern was shared also by our con-
trol group and it seems probable that the predictions of
Roman and colleagues14 are not fully representative of
the very young subjects to which our study groups
belong. The choice of Roman and colleagues as refer-
ence is justified by the similarity in study design and
measurement sites and by the fact that corresponding
reports containing data on aortic dimensions23,24 also
showed similar underrepresentation of the very young.
The reason that the distal autograft did not show dilata-
Fig 3. Time-related changes in the mean Z-values ± SEM of the distal part of the autograft and the ascending
aorta in patients and respective control subjects.
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tion similar to that of the proximal part is possibly due
to the fact that the former was measured near the distal
anastomosis. Suturing promotes fibrosis, which in turn
could counteract passive dilation. The fate of the allo-
graft in the pulmonic position is of concern and will
require repeated operations in the future, even though
the homografts in our small series continue to this time
to perform well with only minor gradients, all below 30
mm Hg. This finding is in contrast to our experience
with homografts in truncus arteriosus, in which
increasing gradients and early dysfunction are fre-
quently encountered. A tentative explanation for the
maintained homograft function in the patients under-
going the Ross procedure may be the normal right
ventricular outflow tract below the harvested pul-
monary valve and subsequently below the homograft.
Heinemann and colleagues15 showed that an absence of
flow disturbances and gradients (even mild) improves
the longevity of conduits.
In conclusion, we find that at midterm follow-up of
the Ross operation in infancy, the pulmonary autograft
shows evidence of normal growth after an initial pas-
sive dilation.
We thank Dr Thomas Gilljam for including one of his
patients and medical student Endre Szarka for excellent assis-
tance with data entry and calculation operations.
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